We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The National Institute for Health and Clinical Excellence (NICE) … has stated that the cancer drug, Glivec (imatinib), recommended for treating gastrointestinal stromal tumours would no longer be used on NHS, as it failed to possess evidences regarding its long-term effectiveness. TopNews
